Nomura/Instinet Downgrades Sucampo Pharmaceuticals (SCMP) to Neutral Following Acquisition
Tweet Send to a Friend
Nomura/Instinet downgraded Sucampo Pharmaceuticals (NASDAQ: SCMP) from Buy to Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
